Park Ha Biological Technology Co., Ltd. Ordinary Shares
Park Ha Biological Technology Co., Ltd. Ordinary Shares Fundamental Analysis
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) shows strong financial fundamentals with a PE ratio of 2.05, profit margin of 20.09%, and ROE of 38.00%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 83.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BYAH's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBYAH demonstrates superior asset utilization.
Valuation Score
ExcellentBYAH trades at attractive valuation levels.
Growth Score
WeakBYAH faces weak or negative growth trends.
Financial Health Score
ExcellentBYAH maintains a strong and stable balance sheet.
Profitability Score
ExcellentBYAH achieves industry-leading margins.
Key Financial Metrics
Is BYAH Expensive or Cheap?
P/E Ratio
BYAH trades at 2.05 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BYAH's PEG of 0.02 indicates potential undervaluation.
Price to Book
The market values Park Ha Biological Technology Co., Ltd. Ordinary Shares at 0.65 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.14 times EBITDA. This is generally considered low.
How Well Does BYAH Make Money?
Net Profit Margin
For every $100 in sales, Park Ha Biological Technology Co., Ltd. Ordinary Shares keeps $20.09 as profit after all expenses.
Operating Margin
Core operations generate 33.32 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $38.00 in profit for every $100 of shareholder equity.
ROA
Park Ha Biological Technology Co., Ltd. Ordinary Shares generates $15.52 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Park Ha Biological Technology Co., Ltd. Ordinary Shares generates strong operating cash flow of $1.24M, reflecting robust business health.
Free Cash Flow
Park Ha Biological Technology Co., Ltd. Ordinary Shares generates strong free cash flow of $1.13M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.67 in free cash annually.
FCF Yield
BYAH converts 67.26% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
2.05
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.65
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.53
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.05
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.87
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.38
vs 25 benchmark
ROA
Return on assets percentage
0.16
vs 25 benchmark
ROCE
Return on capital employed
0.51
vs 25 benchmark
How BYAH Stacks Against Its Sector Peers
| Metric | BYAH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 2.05 | 24.85 | Better (Cheaper) |
| ROE | 38.00% | 1165.00% | Weak |
| Net Margin | 20.09% | 749.00% | Weak |
| Debt/Equity | 0.05 | 0.76 | Strong (Low Leverage) |
| Current Ratio | 1.87 | 9.23 | Neutral |
| ROA | 15.52% | 1271.00% | Weak |
BYAH outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Park Ha Biological Technology Co., Ltd. Ordinary Shares's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
EPS CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
FCF CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary